p-Toluenesulfonylmethyl isocyanide - CAS 36635-61-7
Catalog: |
BB023023 |
Product Name: |
p-Toluenesulfonylmethyl isocyanide |
CAS: |
36635-61-7 |
Synonyms: |
1-(isocyanomethylsulfonyl)-4-methylbenzene |
IUPAC Name: | 1-(isocyanomethylsulfonyl)-4-methylbenzene |
Description: | p-Toluenesulfonylmethyl isocyanide (CAS# 36635-61-7) is used as a synthetic reagent in the preparation of variety or biologically active heterocycles such as pyrroles and imidazoles. Tosylmethyl Isocyanide is reported to inhibit [Fe]-hydrogenase with very high affinity. |
Molecular Weight: | 195.24 |
Molecular Formula: | C9H9NO2S |
Canonical SMILES: | CC1=CC=C(C=C1)S(=O)(=O)C[N+]#[C-] |
InChI: | InChI=1S/C9H9NO2S/c1-8-3-5-9(6-4-8)13(11,12)7-10-2/h3-6H,7H2,1H3 |
InChI Key: | CFOAUYCPAUGDFF-UHFFFAOYSA-N |
Boiling Point: | 400.9 °C at 760 mmHg |
Melting Point: | 110-115 °C |
Purity: | 95 % |
Density: | 1.24 g/cm3 |
Appearance: | Pale yellow to light brown crystalline powder |
Storage: | -20 °C |
MDL: | MFCD00000005 |
LogP: | 1.95700 |
GHS Hazard Statement: | H301+H311+H331 (73.02%): Toxic if swallowed, in contact with skin or if inhaled [Danger Acute toxicity, oral; acute toxicity, dermal; acute toxicity, inhalation] |
Precautionary Statement: | P261, P264, P270, P271, P280, P301+P310, P302+P352, P304+P340, P311, P312, P321, P322, P330, P361, P363, P403+P233, P405, and P501 |
Signal Word: | Danger |
Publication Number | Title | Priority Date |
CN-113336682-A | Synthesis method of sulfonyl carbamate | 20210805 |
CN-113292721-A | Polythiourea compound and preparation method and application thereof | 20210519 |
CN-113480476-A | 4-fluoropyridine derivative and preparation method and application thereof | 20210423 |
CN-113149829-A | Preparation method of bipidedic acid | 20210331 |
CN-112707867-A | Novel method for synthesizing 2- (1-methylimidazol-5-yl) ethylamine hydrochloride | 20210204 |
PMID | Publication Date | Title | Journal |
32058240 | 20200315 | Design, synthesis and biological evaluation of novel 2-(5-aryl-1H-imidazol-1-yl) derivatives as potential inhibitors of the HIV-1 Vpu and host BST-2 protein interaction | European journal of medicinal chemistry |
31753802 | 20200101 | Design, synthesis and biological evaluation of imidazole and oxazole fragments as HIV-1 integrase-LEDGF/p75 disruptors and inhibitors of microbial pathogens | Bioorganic & medicinal chemistry |
22590425 | 20120501 | 4-(2,3-Dimeth-oxy-phen-yl)-1H-pyrrole-3-carbonitrile | Acta crystallographica. Section E, Structure reports online |
22259504 | 20120101 | 4-(2,2-Difluoro-1,3-benzodioxol-4-yl)-1H-pyrrole-3-carbonitrile | Acta crystallographica. Section E, Structure reports online |
21906854 | 20111101 | Synthesis and antimicrobial activity of amido linked pyrrolyl and pyrazolyl-oxazoles, thiazoles and imidazoles | European journal of medicinal chemistry |
Complexity: | 298 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 195.03539970 |
Formal Charge: | 0 |
Heavy Atom Count: | 13 |
Hydrogen Bond Acceptor Count: | 3 |
Hydrogen Bond Donor Count: | 0 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 195.03539970 |
Rotatable Bond Count: | 2 |
Topological Polar Surface Area: | 46.9 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 1.3 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Nitrogen Compounds
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS